Covered recipient · General Payments record
YOUSUF KHAN
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$2,835.31
- Reported across 205 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $319.99 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $167.19 | 10 |
| Novo Nordisk AS | $35.38 | 2 |
| DEXCOM, INC. | $32.28 | 1 |
| ABBVIE INC. | $28.70 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $26.12 | 1 |
| SANOFI-AVENTIS U.S. LLC | $17.08 | 1 |
| Lilly USA, LLC | $13.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $9.02 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124845560 | CMS |
| Abbott Laboratories | $6.35 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124845562 | CMS |
| Abbott Laboratories | $24.01 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124845564 | CMS |
| Abbott Laboratories | $16.86 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124845570 | CMS |
| Abbott Laboratories | $15.71 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124845566 | CMS |
| Abbott Laboratories | $24.45 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124845568 | CMS |
| Abbott Laboratories | $12.96 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124845572 | CMS |
| Abbott Laboratories | $18.92 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124845574 | CMS |
| Abbott Laboratories | $19.15 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124845576 | CMS |
| Abbott Laboratories | $19.76 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124845578 | CMS |
| ABBVIE INC. | $13.80 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104062920 | CMS |
| ABBVIE INC. | $14.90 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104062922 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $26.12 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086146727 | CMS |
| Dexcom, Inc. | $32.28 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153345031 | CMS |
| Lilly USA, LLC | $13.24 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135455843 | CMS |
| Novo Nordisk Inc | $15.86 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096650958 | CMS |
| Novo Nordisk Inc | $19.52 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097446071 | CMS |
| SANOFI-AVENTIS U.S. LLC | $17.08 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139850828 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.